Clinical Trial Update: A Drug-Drug Interaction Study of Diltiazem and MK-5684 in Healthy Adult Male Participants (MK-5684-011) [Phase 1]

View source ↗

Summary

Phase 1 drug-drug interaction study evaluating diltiazem with MK-5684 in healthy adult male participants has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Diltiazem (diltiazem)
• MK-5684 (MK-5684)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Prostatic Neoplasms | Phase 1 | Status: COMPLETED